Researchers developed a model to determine whether reductions in meticillin-resistant Staphylococcus aureus bloodstream infections alone would make hand hygiene interventions cost-effective. They combined transmission dynamic and decision analytic models to determine the anticipated impact of hand hygiene interventions on MRSA bloodstream infection incidence and evaluate the cost-effectiveness. They conducted the research in a middle-income country.
Here are four study findings:
1. Interventions increasing hand hygiene compliance from a 10 percent baseline to more than 20 percent are likely to be cost-effective solely through reduced MRSA bloodstream infections.
2. Increasing compliance from 10 percent to 40 percent was estimated to cost $2,515 per 10,000 bed-days with 3.8 quality-adjusted life-years gained in a pediatric intensive care unit.
3. Increasing compliance from 10 percent to 40 percent was estimated to cost $1,743 per 10,000 bed-days with 3.7 quality-adjusted life-years gained in an adult ICU.
4. If baseline compliance is not more than 20 percent, the intervention is always cost-effective even with only a 10 percent compliance improvement.
More articles on healthcare quality:
Are physicians overprescribing antibiotics to get higher ratings from patients?
EEOC sues Saint Thomas Health over mandatory flu shot policy
Hospital stays for infection linked to dementia-related brain changes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.